Omega-3 essential fatty acids are helpful in systemically reducing the inflammation of the accessory lacrimal glands of the eyes. In addition, it has been found that these same Omega-3 essential fatty acids are beneficial in controlling meibomitis and chronic lid disease. Dry Eye Omega Benefits® is formulated with a high concentration of the anti-inflammatory Omega-3, EPA (eicosapentanoic acid), and Vitamin D3. It works from within to help alleviate dry eye syndrome.

At MEA we are sincere believers in the benefits of Omega 3. However, not all Omega 3 supplements are created equal. It is important to take supplements that are found in their triglyceride form which is naturally occurring and has an absorption rate of 69%. Most products on the market are in ethyl ester form whose absorption rate is much lower, at 20%. Additionally, some of the less expensive over-the-counter brands of Omega 3 may contain high levels of PCBs and heavy metals such as mercury.

MEA carries Physician Recommended Nutriceuticals (PRN) Dry Eye Omega which stands behind all of its products with the confidence that each one is of the purest, highest quality marine source Omega 3 available. These products are available through physician recommendation only and are available at Matossian Eye Associates.

Dry Eye Omega Benefit®

  • Natural Triglyceride Form for Maximum Absorption
  • Highly Purified and Concentrated
  • Molecularly Distilled in a Licensed Facility
  • Independent Laboratory Tested
  • Free of Mercury, PCBs, and Dioxins
  • Free of Pro-Inflammatory Omega-6s!

Xiidra™

The FDA recently approved Xiidra™ as a treatment for the signs and symptoms of dry eye disease. It is the first and only prescription eye drop approved for both the signs and symptoms of dry eye disease. This remarkable product is available by prescription only and is now available at all major pharmacies. Matossian Eye Associates was one of the premier clinical trial sites to offer valuable contributions and interest in this important milestone, playing an instrumental role in making this new treatment available for our patients.

Owner, Founder, and Chief Medical officer of Matossian Eye Associates and Principal Investigator in the Xiidra™ clinical study Cynthia Matossian, MD, FACS said, “With the epidemic of Dry Eye Disease, we are fortunate to have an additional medicine like Xiidra™ to bring relief to the millions who suffer dry eye symptoms daily.”

Matossian Eye Associates is one of the few practices in the greater area to have samples of Xiidra™ for our patients to try. If you are experiencing stinging or burning eyes, a gritty or scratchy sensation, discomfort in contact lenses, blurred vision, light sensitivity, redness, excessive tearing, and a reliance on artificial tears to get through the day, please call us at 1(800) 708-8800 to schedule a dry eye consult by a fellowship trained, board certified physicians in our Certified Dry Eye Center of Excellence! Please click the video below to hear actress Jennifer Aniston’s experience with dry eye.

TrueTear™

Matossian Eye Associates was selected as the first practice in the greater Delaware Valley area to introduce TrueTear as part of its Certified Dry Eye Center of Excellence. TrueTear™ is an FDA approved novel device to temporarily increase your own natural tear production with user-controllable neurostimulation.  TrueTear™ causes your eyes to produce natural tears using tiny pulses of energy with no pain whatsoever.

  • The TrueTear™ tips stimulate a nerve in the nasal cavity with tiny pulses of energy, sending out nerve signals to the brain.
  • The brain then sends nerve signals to the tear glands surrounding the eyes to temporarily increase tear production.
  • The glands surrounding the eyes react and temporarily produce real tears.